| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 13.66× | 13.66× | 12.95× | 12.14× | 11.86× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.91× | 1.91× | 1.85× | 1.70× | 2.00× | ||
| 1.04× | 1.04× | 1.65× | 1.90× | 0.00× | ||
| 0.69× | 0.69× | 1.13× | 1.24× | 0.00× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 11.86 | 12.14 | 12.95 | 13.66 | 13.66 | |
| Asset Turnover | 2.00 | 1.70 | 1.85 | 1.91 | 1.91 | |
| Cash Conversion (CFO/Net Income) | 0.00 | 1.90 | 1.65 | 1.04 | 1.04 | |
| CFO/EBITDA | 0.00 | 1.24 | 1.13 | 0.69 | 0.69 |